Chemours director awarded 7,182 stock units

Chemours Co director Sean D. Keohane received a grant of 7,182 stock units of Chemours common stock at a price of $0.00 per unit.

Rhea-AI Filing Summary

Chemours Co director Sean D. Keohane received a grant of 7,182 stock units of Chemours common stock at a price of $0.00 per unit. These stock units will convert one-for-one into Chemours common stock when he separates from service on the Board.

The grant includes deferred stock units and related dividend equivalent units. Following this award, Keohane holds a total of 72,555.1777 shares and stock units of Chemours common stock directly.

Insider Trade Summary

Grant/Award: 7,182 shares

Grant/Award 1 txn

Insider Keohane Sean D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,182	$0.00	$0.00

Holdings After Transaction: Common Stock — 72,555.1777 shares (Direct)

Footnotes (2)

1. F1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
2. F2. Includes deferred stock units and dividend equivalent units.

Key Figures

Stock units granted: 7,182 units Price per unit: $0.00 per unit Total holdings after grant: 72,555.1777 shares/units

3 metrics

Stock units granted 7,182 units Grant of Chemours common stock units on 2026-05-06

Price per unit $0.00 per unit Grant/award acquisition, non-market transaction

Total holdings after grant 72,555.1777 shares/units Direct ownership of Chemours common stock and stock units

Key Terms

stock units, deferred stock units, dividend equivalent units, grant, award, or other acquisition

4 terms

stock units financial

"Represents stock units that will convert one-for-one to Chemours common stock"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

deferred stock units financial

"Includes deferred stock units and dividend equivalent units."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

dividend equivalent units financial

"Includes deferred stock units and dividend equivalent units."

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Chemours (CC) director Sean D. Keohane report in this Form 4?

Sean D. Keohane reported receiving 7,182 Chemours stock units. These units are a grant of Chemours common stock at $0.00 per unit and will convert one-for-one into Chemours common shares when he separates from service on the company’s Board of Directors.

How many Chemours (CC) shares and units does Sean D. Keohane hold after this transaction?

After the grant, Sean D. Keohane holds 72,555.1777 shares and stock units. This total reflects his direct ownership of Chemours common stock, including the newly granted stock units, deferred stock units, and associated dividend equivalent units reported in the filing.

What type of securities did Sean D. Keohane receive from Chemours (CC)?

He received stock units linked to Chemours common stock. The filing explains these are stock units that will convert one-for-one into Chemours common shares upon his separation from service on the Board and include deferred stock units and dividend equivalent units.

How are Sean D. Keohane’s Chemours (CC) stock units converted into shares?

The stock units convert one-for-one into Chemours common stock. According to the filing, this conversion occurs when Keohane separates from service on the Chemours Board, meaning each stock unit becomes one share of Chemours common stock at that time.

What does the $0.00 price per share mean in Sean D. Keohane’s Chemours (CC) grant?

The $0.00 price indicates a compensation-related grant, not a market purchase. The 7,182 stock units were awarded as a grant or other acquisition, so Keohane did not pay cash per unit for this Chemours common stock award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keohane Sean D

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		7,182(1)	A	$0	72,555.1777(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)